Connective Tissue Disorders and Cardiovascular Complications: The Indomitable Role of Transforming Growth Factor-β Signaling
- 23 November 2021
- book chapter
- Published by Springer Nature
- Vol. 1348, 161-184
Abstract
Marfan Syndrome (MFS) and Loeys-Dietz Syndrome (LDS) represent heritable connective tissue disorders that segregate with a similar pattern of cardiovascular defects (thoracic aortic aneurysm, mitral valve prolapse/regurgitation, and aortic dilatation with regurgitation). This pattern of cardiovascular defects appears to be expressed along a spectrum of severity in many heritable connective tissue disorders and raises suspicion of a relationship between the normal development of connective tissues and the cardiovascular system. With overwhelming evidence of the involvement of aberrant Transforming Growth Factor-beta (TGF-β) signaling in MFS and LDS, this signaling pathway may represent the common link in the relationship between connective tissue disorders and their associated cardiovascular complications. To further explore this hypothetical link, this chapter will review the TGF-β signaling pathway, the heritable connective tissue syndromes related to aberrant TGF-β signaling, and will discuss the pathogenic contribution of TGF-β to these syndromes with a primary focus on the cardiovascular system. Keywords Aorta Aneurysm Extracellular matrix Collagen Metalloproteinase Shprintzen-Goldberg syndrome Thoracic aortic aneurysm and dissection syndrome Hereditary hemorrhagic telangiectasia (HHT) Marfan syndrome (MFS) Loeys-Dietz syndrome (LDS) Ehlers-Danlos syndrome (EDS) Aortic aneurysm thoracic (AAT) Aneurysm-osteoarthritis syndrome (AOS) Arterial tortuosity syndrome (ATS) Primary pulmonary hypertension Fibrodysplasia Ossificans progressive (FOP) Familial thoracic aortic aneurysm and dissection syndrome (FTAAD) Transforming growth factor-β (TGF-β) Endoglin Mitral valve Arteriovenous malformation SMAD TGF-β receptor BMP receptor Activin receptor-like kinase (ALK) Mitogen-activated protein kinase (MAPK) Extracellular signal related kinase (ERK) Fibrillin Curacao diagnostic criteria Genetic testing Beta blockers Losartan Doxycycline IntegrinsKeywords
This publication has 147 references indexed in Scilit:
- Genetic Testing in Aortic Aneurysm Disease: PROCardiology Clinics, 2010
- Pharmacological inhibition of integrin αvβ3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis #Hepatology, 2009
- Extracellular microfibrils: contextual platforms for TGFβ and BMP signalingCurrent Opinion in Cell Biology, 2009
- Hereditary haemorrhagic telangiectasia: a clinical and scientific reviewEuropean Journal of Human Genetics, 2009
- p38 MAPK Is an Early Determinant of Promiscuous Smad2/3 Signaling in the Aortas of Fibrillin-1 (Fbn1)-null MiceJournal of Biological Chemistry, 2009
- TRAF6 Mediates Smad-Independent Activation of JNK and p38 by TGF-βMolecular Cell, 2008
- Thrombospondin-1 and transforming growth factor beta are pro-inflammatory molecules in rheumatoid arthritisTranslational Research, 2008
- TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcAThe EMBO Journal, 2007
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Immunopathology and the gene therapy of lupusGene Therapy, 2003